Immunotherapy trials: current status and future directions with special emphasis on biologic drugs.
D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000032:analysis / Q000302:isolation & purification / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000939:Epitopes / Q000032:analysis; D005260:Female; D005818:Genetic Engineering / Q000379:methods; D006801:Humans; D007114:Immunization / Q000379:methods; D007116:Immunization, Passive; D007167:Immunotherapy / Q000639:trends; D007945:Leukemia, Lymphoid / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D010455:Peptides; D014612:Vaccines / Q000302:isolation & purification
D000277:Adjuvants, Pharmaceutic; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000939:Epitopes; D010455:Peptides; D014612:Vaccines